SUSQUEHANNA INTERNATIONAL GROUP, LLP - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 15 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q2 2023$11,622
-43.8%
10,470
-49.3%
0.00%
Q1 2023$20,668
+13.8%
20,670
-1.3%
0.00%
Q4 2022$18,167
+65.2%
20,935
+59.7%
0.00%
Q2 2022$11,000
-63.3%
13,110
+31.1%
0.00%
Q1 2022$30,000
-91.0%
10,000
-84.7%
0.00%
Q4 2021$334,00065,2240.00%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$771,0000.24%
Kynam Capital Management, LP 739,649$954,0000.20%
RA Capital Management 6,991,003$9,018,0000.19%
Octagon Capital Advisors LP 450,000$581,0000.10%
Ikarian Capital, LLC 219,501$283,0000.06%
UBS OCONNOR LLC 613,931$792,000,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,277,519$1,648,0000.00%
ROCKY MOUNTAIN ADVISERS, LLC 1,200$2,0000.00%
CSS LLC/IL 38,721$50,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$35,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders